Clinical Trial

Performing a Low-dose, Whole-body Angiography as the First Element of an Imaging Assessment Following Stroke / TIA

Study acronym: VASCU
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 10, 2025 (before its estimated June 12, 2026 completion). Its status may not reflect the trial's current state.
Summary
The main objective of this study is to compare two post-stroke/TIA (transient ischemic attack) imaging strategies in terms of the number of clinically important (i.e. requiring specific treatment according to current recommendations) lesions detected. The first strategy is the current/usual strategy in each participating centre and the second strategy consists in starting the post-stroke/TIA imaging assessment by a whole-body, low-dose angiography and subsequently resorting to elements of the usual strategy if required.
Protocol Amendment History 10 amendments
This ClinicalTrials.gov record has been amended 10 times since 2016-01-20; most recent amendment 2025-03-07.
Status change: Not Yet Recruiting → Recruiting 2019-11-05
Trial Details
NCT Number NCT02662751
Lead Sponsor Centre Hospitalier Universitaire de Nīmes
Conditions Stroke, Ischemic Attack, Transient
Enrollment 260 participants
Start Date 2019-10-21
Primary Completion 2026-06-12 (estimated)
Study Completion 2026-06-12 (estimated)
Updated on ClinicalTrials.gov 2025-03-10